Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine add-on therapy in major depression
NCT00568672Phase 3Withdrawn
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in major depressive disorder (MDD), sponsored by Charité – Universitätsmedizin Berlin. Planned start Oct 2007; status: withdrawn.
02
Drugs
olanzapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00568672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568672.